Evidence map›Paper›PMID 16488890›Full record

ArticleThe Journal of biological chemistry2006

Human prolyl-4-hydroxylase alpha(I) transcription is mediated by upstream stimulatory factors.

Li Chen, Ying H Shen, Xinwen Wang, Jing Wang, Yehua Gan, Nanyue Chen, Jian Wang, Scott A LeMaire, Joseph S Coselli, Xing Li Wang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Collagen Prolyl 4-Hydroxylase: An Emerging Key Player in Cardiac Fibrosis.Journal of cardiovascular translational research · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Li ChenSection of Adult Cardiothoracic Service, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.
Ying H Shen
Xinwen Wang
Jing Wang
Yehua Gan
Nanyue Chen
Jian Wang
Scott A LeMaire
Joseph S Coselli
Xing Li Wang
St. Luke's Episcopal Hospital · USBaylor College of Medicine · USThe University of Texas MD Anderson Cancer Center · US

Funding

Molecular Mechanism for HCMV Mediated AtherogenesisR01HL071608 · NHLBI · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI WANG, XING LI L · 2002 to 2005
$1.6M
NO, Genotype Dependent &Environment Specific RegulationR01HL066053 · NHLBI · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI WANG, XING LI L · 2001 to 2004
$1.5M
Matrix Metalloproteinases in Thoracic Aortic DissectionK08HL080085 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LEMAIRE, SCOTT A · 2005 to 2009
$682k
NHLBI NIH HHS HL066053NHLBI NIH HHS HL71608NHLBI NIH HHS K08 HL080085NHLBI NIH HHS R01 HL066053NHLBI NIH HHS R01 HL071608
6 · The paper itself

Abstract

Prolyl-4-hydroxylase alpha(I) (P4Halpha(I)) is the rate-limiting subunit for P4H enzyme activity, which is essential for procollagen hydroxylation and secretion. In the current study, we have characterized the human P4Halpha(I) promoter for transcription factors and DNA elements regulating P4Halpha(I) expression. Using a progressive deletion cloning approach, we have constructed pGL3-P4Halpha(I) recombinant plasmids. We have identified a positive regulatory region at the positions of bp -184 to -97 responsible for approximately 80% of the P4Halpha(I) promoter efficiency. Three E-boxes were located within this region, and the E-box at position bp -135 explains most of the regulatory capacity. Upstream stimulatory factors (USF1/USF2) were shown to bind on the E-box using chromatin immunoprecipitation assay. Suppression of USF1 and/or USF2 using specific short interference RNA resulted in a significant reduction in P4Halpha(I) promoter activity, and overexpressed USF1 or USF2 increased P4Halpha(I) promoter activity significantly. Although transforming growth factor beta1 increased the USF1/USF2-E-box binding and P4Halpha(I) promoter activity, this up-regulatory effect can be largely prevented by USF1/USF2-specific short interference RNA. On the other hand, cigarette smoking extracts, which have been shown to suppress P4Halpha(I) expression, inhibited the binding between the USF1/USF2 and E-box, resulting in a reduced P4Halpha(I) promoter activity. Furthermore, the E-box on the P4Halpha(I) promoter appeared to indiscriminately bind with either USF1 or USF2, with a similar outcome on the promoter efficiency. In conclusion, our study shows that USF1/USF2 plays a critical role in basal P4Halpha(I) expression, and both positive (transforming growth factor beta1) and negative (cigarette smoking extract) regulators appear to influence the USF-E-box interaction and affect P4Halpha(I) expression.

Indexed as

Gene Expression RegulationTranscription, GeneticBase SequenceBinding SitesChromatin ImmunoprecipitationDNADNA-Binding ProteinsDNA PrimersDown-RegulationHeLa CellsHumansLuciferasesModels, GeneticMolecular Sequence DataPlasmidsProcollagen-Proline DioxygenaseDNADNA-Binding ProteinsDNA PrimersLuciferasesP4HA1 protein, humanProcollagen-Proline DioxygenaseRNA, MessengerRNA, Small InterferingTGFB1 protein, humanTranscription FactorsTransforming Growth Factor betaTransforming Growth Factor beta1

Identifiers

PMID16488890
PMCPMC2819823
OpenAlexW2020940277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.